At Innocan, we are committed to revolutionizing chronic pain treatment through advanced scientific innovation. Our unique injectable delivery platform, LPT-CBD, utilizes liposome technology that enables exact dosing and controlled release of synthetic Cannabidiol (CBD) into the bloodstream.

Advantages of LPT-CBD

LPT-CBD stands out with several key benefits over standard CBD applications and other treatments:

• High Bioavailability: Nearly 100% bioavailability of synthetic CBD for maximum therapeutic effect. 
• Precise Dosing & Prolonged Release: Ensures exact dosing with sustained release, maintaining therapeutic levels for extended periods. 
• Extended Efficacy: A single injection lasts up to 4 weeks, replacing the need for twice-daily oral consumption. 

How It Works 

Liposomes are spherical vesicles composed of one or more layers of lipids that can carry drugs through the human vascular system. They are biocompatible and non-toxic and can improve the drug performance.

A hydrogel liposome containing CBD ready for delivery

Administration & Distribution 

LPT-CBD is administered subcutaneously (under the skin), where the liposomes remain at the injection site, allowing for slow, controlled release of cannabidiol to target organs. This delivery method enhances bioavailability, outperforming conventional CBD delivery routes such as oral, sublingual, or inhalation.

Expected Bioavailability of Innocan LPT-CBD following injection

Proven Efficacy & Safety 

In comprehensive pre-clinical studies, LPT-CBD has demonstrated favorable safety profile and efficacy when tested across various animal models for chronic pain. These studies, conducted under rigorous standards, highlight the potential of our technology to significantly improve treatment outcomes. 

Intellectual Property 

Our commitment to innovation is reflected in our robust intellectual property portfolio. To date, we have been granted 4 patents, with 31 additional patents pending across 8 patent families in the field of drug delivery and wellness.

At Innocan, our dedication to scientific advancement drives us to develop therapies that enhance patient care and quality of life.